These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 18191308

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.
    Castilow EM, Meyerholz DK, Varga SM.
    J Immunol; 2008 Feb 15; 180(4):2376-84. PubMed ID: 18250447
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.
    Cyr SL, Jones T, Stoica-Popescu I, Burt D, Ward BJ.
    Vaccine; 2007 Apr 20; 25(16):3228-32. PubMed ID: 17374422
    [Abstract] [Full Text] [Related]

  • 48. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.
    Fleeton MN, Chen M, Berglund P, Rhodes G, Parker SE, Murphy M, Atkins GJ, Liljeström P.
    J Infect Dis; 2001 May 01; 183(9):1395-8. PubMed ID: 11294672
    [Abstract] [Full Text] [Related]

  • 49. CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV).
    Hancock GE, Heers KM, Smith JD, Scheuer CA, Ibraghimov AR, Pryharski KS.
    Vaccine; 2001 Sep 14; 19(32):4874-82. PubMed ID: 11535341
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.
    Johnson JE, McNeil LK, Megati S, Witko SE, Roopchand VS, Obregon JH, Illenberger DM, Kotash CS, Nowak RM, Braunstein E, Yurgelonis I, Jansen KU, Kalyan NK, Sidhu MK.
    Immunol Lett; 2013 Feb 14; 150(1-2):134-44. PubMed ID: 23261719
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines.
    Moghaddam A, Olszewska W, Wang B, Tregoning JS, Helson R, Sattentau QJ, Openshaw PJ.
    Nat Med; 2006 Aug 14; 12(8):905-7. PubMed ID: 16862151
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice.
    Dakhama A, Lee YM, Ohnishi H, Jing X, Balhorn A, Takeda K, Gelfand EW.
    J Allergy Clin Immunol; 2009 Jan 14; 123(1):138-145.e5. PubMed ID: 19056111
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic.
    Dollenmaier G, Mosier SM, Scholle F, Sharma N, McKnight KL, Lemon SM.
    Virology; 2001 Mar 15; 281(2):216-30. PubMed ID: 11277694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.